Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1017/S0007114507868528. Epub 2007 Nov 22.
Collaborators, Affiliations
- PMID: 18031592
- DOI: 10.1017/S0007114507868528
Randomized Controlled Trial
Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial
Jordi Salas-Salvadó et al. Br J Nutr. 2008 Jun.
Abstract
The aim of the study was to compare the effect of the administration of a mixture of fibres on body weight-loss, satiety, lipid profile and glucose metabolism. We included 200 overweight or obese patients in a parallel, double-blind, placebo-controlled clinical trial, who were randomised to receive, in the context of an energy-restricted diet for a period of 16 weeks, a mixed fibre dose (3 g Plantago ovata husk and 1 g glucomannan) twice (b.i.d. group) or three times daily (t.i.d. group) or placebo. Weight change was the primary efficacy endpoint. Satiety, dietary compliance, lipid profile, glucose tolerance, insulin resistance and high-sensitivity C-reactive protein were secondary endpoints. Weight loss tended to be higher after both doses of fibre (-4.52 (SD 0.56) and -4.60 (SD 0.55) kg) than placebo (-0.79 (SD 0.58) kg); the differences in changes between groups were not statistically significant. Postprandial satiety increased in both fibre groups compared to the placebo. The differences between groups in LDL-cholesterol levels were significant (P = 0.03), with greater reductions in the two fibre-supplemented groups (-0.38 (SD 0.10) and -0.24 (SD 0.09) mmol/l in the b.i.d. and t.i.d. groups v. -0.06 (SD 0.09) mmol/l in placebo group). A similar pattern was observed for changes in total cholesterol:HDL-cholesterol and HDL-cholesterol:LDL-cholesterol ratios. Interventions were well tolerated and had no effects on HDL-cholesterol, glucose and insulin concentrations, glucose tolerance or high-sensitivity C-reactive protein. In conclusion, a 16-week dietary supplement of soluble fibre in overweight or obese patients was well tolerated, induced satiety and had beneficial effects on some CVD risk factors, the most important of which was a significant decrease in plasma LDL-cholesterol concentrations.
Similar articles
- Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial.
Solà R, Bruckert E, Valls RM, Narejos S, Luque X, Castro-Cabezas M, Doménech G, Torres F, Heras M, Farrés X, Vaquer JV, Martínez JM, Almaraz MC, Anguera A. Solà R, et al. Atherosclerosis. 2010 Aug;211(2):630-7. doi: 10.1016/j.atherosclerosis.2010.03.010. Epub 2010 Mar 17. Atherosclerosis. 2010. PMID: 20413122 Clinical Trial. - The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals.
Pal S, Khossousi A, Binns C, Dhaliwal S, Ellis V. Pal S, et al. Br J Nutr. 2011 Jan;105(1):90-100. doi: 10.1017/S0007114510003132. Epub 2010 Aug 23. Br J Nutr. 2011. PMID: 20727237 Clinical Trial. - Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk.
Wood RJ, Fernandez ML, Sharman MJ, Silvestre R, Greene CM, Zern TL, Shrestha S, Judelson DA, Gomez AL, Kraemer WJ, Volek JS. Wood RJ, et al. Metabolism. 2007 Jan;56(1):58-67. doi: 10.1016/j.metabol.2006.08.021. Metabolism. 2007. PMID: 17161227 Clinical Trial. - Psyllium fibre and the metabolic control of obese children and adolescents.
Moreno LA, Tresaco B, Bueno G, Fleta J, Rodríguez G, Garagorri JM, Bueno M. Moreno LA, et al. J Physiol Biochem. 2003 Sep;59(3):235-42. doi: 10.1007/BF03179920. J Physiol Biochem. 2003. PMID: 15000455 Review. - Effect of the novel functional fibre, polyglycoplex (PGX), on body weight and metabolic parameters: A systematic review of randomized clinical trials.
Onakpoya IJ, Heneghan CJ. Onakpoya IJ, et al. Clin Nutr. 2015 Dec;34(6):1109-14. doi: 10.1016/j.clnu.2015.01.004. Epub 2015 Jan 13. Clin Nutr. 2015. PMID: 25616600 Review.
Cited by
- Effect of the yellow passion fruit peel flour (Passiflora edulis f. flavicarpa deg.) in insulin sensitivity in type 2 diabetes mellitus patients.
de Queiroz Mdo S, Janebro DI, da Cunha MA, Medeiros Jdos S, Sabaa-Srur AU, Diniz Mde F, Dos Santos SC. de Queiroz Mdo S, et al. Nutr J. 2012 Oct 22;11:89. doi: 10.1186/1475-2891-11-89. Nutr J. 2012. PMID: 23088514 Free PMC article. Clinical Trial. - Association between dietary patterns and metabolic syndrome in a sample of Portuguese adults.
Fonseca MJ, Gaio R, Lopes C, Santos AC. Fonseca MJ, et al. Nutr J. 2012 Sep 3;11:64. doi: 10.1186/1475-2891-11-64. Nutr J. 2012. PMID: 22943133 Free PMC article. - Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1-36) following low doses of a whey protein-rich nutraceutic.
Sukkar SG, Vaccaro A, Ravera GB, Borrini C, Gradaschi R, Massa Sacchi-Nemours A, Cordera R, Andraghetti G. Sukkar SG, et al. Med J Nutrition Metab. 2013;6(3):259-266. doi: 10.1007/s12349-013-0121-7. Epub 2013 Feb 5. Med J Nutrition Metab. 2013. PMID: 24319546 Free PMC article. - Vegetarian and vegan diets: benefits and drawbacks.
Wang T, Masedunskas A, Willett WC, Fontana L. Wang T, et al. Eur Heart J. 2023 Sep 21;44(36):3423-3439. doi: 10.1093/eurheartj/ehad436. Eur Heart J. 2023. PMID: 37450568 Free PMC article. - Effects of soluble dietary fiber on low-density lipoprotein cholesterol and coronary heart disease risk.
Bazzano LA. Bazzano LA. Curr Atheroscler Rep. 2008 Dec;10(6):473-7. doi: 10.1007/s11883-008-0074-3. Curr Atheroscler Rep. 2008. PMID: 18937894 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials